期刊
ONCOTARGET
卷 8, 期 45, 页码 78265-78276出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.19432
关键词
metastasis; patient-derived xenograft; preclinical model; Wnt signaling; Ewing sarcoma
资金
- National Institutes of Health grant [1R01CA138212-01]
- Liddy Shriver Sarcoma Initiative
- Core Grant supporting the Sidney Kimmel Comprehensive Cancer Center [2P30 CA006973]
- Giant Food Children's Cancer Research Fund
- National Pediatric Cancer Foundation
- Pablove Foundation Pediatric Cancer Research grant
- SARC Sarcoma SPORE Career Development Award [5U54CA168512-02]
- Strategic Research Fund of the Heinrich-Heine University
The most pressing unmet clinical need for patients with Ewing sarcoma (ES) is the prevention and treatment of metastasis. The Wnt signaling pathway regulates a number of cellular functions associated with metastasis, including proliferation, motility, and stem cell self-renewal. Functional interaction between Wnt ligands and their receptors requires palmitoylation by Porcupine (Porcn), making this an ideal therapeutic target. We studied the effect of WNT974, a potent, selective Porcn inhibitor, on ES metastasis. In vitro, WNT974 does not affect ES proliferation or sarcosphere formation, but suppresses multiple transcriptional regulators of metastasis and inhibits cell migration. In vivo, in an orthotopic implantation/amputation model of spontaneous distant metastasis, single agent WNT974 treatment leads to a significant delay in formation of lung metastasis and a substantial improvement in post-amputation survival without a major effect on primary tumor growth. The drug produces no survival benefit in a tail vein injection model, supporting the hypothesis that WNT974 inhibits early steps in the metastatic cascade, such as migration and invasion. Our findings strongly implicate Wnt signaling in the early steps of ES metastasis and demonstrate that WNT974 has the potential to significantly improve the survival of ES patients through the specific inhibition of metastasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据